Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04317924

Pneumostasis With Use of Bio-absorbable Mesh and Fibrin Sealant in Lung Resection

Use of Polyglycolic Acid Felt for Air-leak Prevention After Lung Resection

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Boston Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prolonged air leak, defined as air leak present 5 days after lung resection, is one of the most common complications after lung resection. This leads to patient discomfort (as the chest tube has to stay in place while air leak is present), prolonged stay, and increased cost. NeoVeil is a bioabsorbable glycolic acid which has been used in Japan and other Asian countries for air leak prevention after lung resections. NeoVeil is impregnated with fibrin sealant materials and is placed on the lung surface at the time of operation. It then acts as a scaffold on resected area which is prone to air leak. This randomized clinical trial will be the first in the United States to test its efficacy for air leak prevention.

Conditions

Interventions

TypeNameDescription
DEVICEPolyglycolic acid feltNeoveil is a polyglycolic acid felt that has been shown to decrease the incidence of prolonged air leak after lung resection in Japan.
OTHERStandard of careStandard of care after air leak post lung resection

Timeline

Start date
2020-10-01
Primary completion
2022-06-01
Completion
2022-06-01
First posted
2020-03-23
Last updated
2020-08-26

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04317924. Inclusion in this directory is not an endorsement.